Biocomposites
-
Hospitals
Biocomposites expands its international presence by opening new sales and distribution office in Italy
Biocomposites SRL will support sales of STIMULAN, NanoBone, genex and SYNICEM Spacers throughout Italy New team has been hired and first…
Read More » -
Biologics
Biocomposites’ investee Renovos Biologics receives FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, RENOVITE® BMP-2
RENOVITE® BMP-2 is being developed as an alternative to bone graft materials for interbody spinal fusion It is the first product…
Read More » -
Recon
Biocomposites expands its product portfolio with the launch of SYNICEM™ spacers in the UK
SYNICEMTM hip, knee and shoulder spacers are preformed and loaded with gentamicin to maintain space and aid treatment of infection. Already…
Read More » -
Biologics
Biocomposites invests in Renovos Biologics – developers of the RENOVITE® nanoclay therapeutic delivery platform
RENOVITE ® nanoclay is a novel therapeutic delivery platform for precision regenerative medicine Investment will help fund pre-market approval for use in…
Read More » -
Biologics
Biocomposites adds proprietary NanoBone® technology to its portfolio through the acquisition of Artoss GmbH
NanoBone® technology complements Biocomposites’ absorbable bone regeneration products Artoss to benefit from Biocomposites established, global distribution network KEELE, England, June 6, 2023 /PRNewswire/…
Read More » -
Biologics
Biocomposites signs distribution agreement with NuVasive Specialized Orthopedics to supply STIMULAN® in Germany
STIMULAN® is the first and only calcium matrix approved as an antibiotic carrier for use in bone and soft tissue…
Read More » -
Biologics
Biocomposites announces new approval for STIMULAN® to treat bacterial infection
STIMULAN® when mixed with antibiotics is the only calcium matrix approved for treating bacterial infection Keele, UK, 7 July 2021…
Read More »